ArticleJournal for immunotherapy of cancer2024

LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy.

Lingjuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.